Back | Next |
home / stock / flgt / flgt message board
Subject | By | Source | When |
---|---|---|---|
If not you are only out 80 bucks. | hippityhop | investorshub | 12/03/2019 3:20:44 PM |
I trade call options for my "LOTTO" homeruns... | bUrRpPPP! | investorshub | 12/03/2019 2:59:38 PM |
So true, good way of putting it. | hippityhop | investorshub | 12/03/2019 2:43:36 PM |
Base hits.... the homerun swingers have the highest | bUrRpPPP! | investorshub | 12/03/2019 2:20:09 PM |
Thx Burp for keeping me informed. You're my | hippityhop | investorshub | 12/03/2019 2:07:13 PM |
growing sector...rising tide raises all ships thing | bUrRpPPP! | investorshub | 12/03/2019 1:45:38 PM |
Thx Burp, is it because they are both | hippityhop | investorshub | 12/03/2019 1:40:18 PM |
BOLD acquired for 100% premium $60 share After | bUrRpPPP! | investorshub | 12/03/2019 1:33:06 AM |
13.30 to fill gap. | hippityhop | investorshub | 11/20/2019 11:17:45 PM |
my pleasure.. btw $12.50 | bUrRpPPP! | investorshub | 11/20/2019 11:08:30 PM |
Thx burp | hippityhop | investorshub | 11/19/2019 7:33:19 PM |
added @ $10.90 | hippityhop | investorshub | 11/19/2019 3:22:27 PM |
added 9.93 today eom | bUrRpPPP! | investorshub | 11/19/2019 12:14:09 AM |
Jumped in 10.68...will add a little next week | bUrRpPPP! | investorshub | 11/16/2019 8:10:43 PM |
Will this company be bought out? | turbo29 | investorshub | 11/12/2019 3:16:08 PM |
$FLGT the future of disease prevention! GENOME testing | TrendTrade2016 | investorshub | 11/11/2019 12:15:22 PM |
$FLGT just a beauty...see ya a 18.41 | TrendTrade2016 | investorshub | 11/09/2019 5:28:37 PM |
* * $FLGT Video Chart 11-05-2019 * * | ClayTrader | investorshub | 11/05/2019 10:11:19 PM |
$FLGT is getting ready to blow up | TrendTrade2016 | investorshub | 10/08/2019 10:18:45 AM |
$FLGT is back in action...long and strong. This | TrendTrade2016 | investorshub | 10/05/2019 9:33:39 AM |
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in innovative cancer therapeutics, today announced that Phase 1 clinical data on its lead therapeutic development candidate, FID-007, to treat Head and Neck cancer, will be p...
Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: F...